Pavan Cheruvu Net Worth & Insider Trades

Pavan Cheruvu - Principal Executive Officer, Axovant Gene Therapies Ltd

As of July 10, 2020

What is Pavan Cheruvu's Net Worth?

The current estimated net worth of Axovant Gene Therapies Ltd's Principal Executive Officer, Pavan Cheruvu, is estimated to be about $62.84K . Pavan Cheruvu owns about 57,836 units of Axovant Gene Therapies Ltd common stock. In the last year at Axovant Gene Therapies Ltd, Pavan Cheruvu has sold an estimated value of $30.14K worth.

What is Pavan Cheruvu's Past Insider Trading?

Pavan Cheruvu's largest purchase order was 37,500 units , worth over $102.64K on July 10, 2020. In total, Pavan Cheruvu has made about 6 transactions over a year of their time at Axovant Gene Therapies Ltd. Pavan Cheruvu usually trades in April and June, with the busiest year in 2019 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pavan Cheruvu

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Pavan Cheruvu's' Mailing Address?

  • Mailing address is C/o Axovant Sciences, Inc. 11 Times Square, 33rd Floor New York NY 10036 NY

What are Axovant Gene Therapies Ltd's Past Insider Trades?

Axovant Gene Therapies Ltd's most recent insider trade came on July 10, 2020 by Atul Pande who bought 10,000 units worth $27.29K . In the last year, insiders at Axovant Gene Therapies Ltd have sold an estimated value of $68.75K and bought an estimated value of $20.2M worth of shares. Insider trading is most common in April, with the busiest year in 2019. The most active traders at the company are Pavan Cheruvu, Principal Executive Officer,  Atul Pande, Director,  and David Nassif, Principal Financial Officer .

Axovant Gene Therapies Ltd. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...